ImmunoGen Stock Analysis
Technical stock analysis for 22 January 2019
ImmunoGen fell by -3.33% in the last day from $5.10 to $4.93 The price has risen in 6 of the last 10 days , but is still down by -9.71% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -0.00 million shares and in total 2.23 million shares bought and sold for approximately $10.98 million.
Close price at the end of the last trading day (Tuesday, 22nd Jan 2019) of the IMGN stock was $4.93. This is 3.33% less than the trading day before Friday, 18th Jan 2019.
During day the stock fluctuated 7.74% from a day low at $4.78 to a day high of $5.15.
30 day high of the IMGN stock price was $5.70 and low was $3.80.
90 day high was $6.48 and low was $3.80.
52 week high for the ImmunoGen - $13.41 and low - $3.80.
ImmunoGen lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.10% during the next 3 months and, with 90% probability hold a price between $2.97 and $4.54 at the end of this period.
There are few to none technical positive signals at the moment. ImmunoGen holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $5.16 and $5.07. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday January 11, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 53 and the stock is currently not being overbought or oversold
Support & Resistance
ImmunoGen finds support from accumulated volume at $4.78.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.37 between high and low, or 7.74%. For the last week, the stock has had a daily average volatility of 6.72%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
ImmunoGen holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.
|IMGN $4.93 $-0.17(-3.33%)|
IMGN is down $0.17 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for IMGN based on the 1-3 month system that more than doubles the S&P 500.
Click here – the IMGN analysis is free »